Parnax Lab Ltd Performance
Open
117
Traded Value (Cr)
3.42 L
Prev. Close
115.4
VWAP
113.59
Volume
2,986
Face Value
10
Parnax Lab Ltd Fundamentals
Parnax Lab Ltd Financials
Resistance and Support
₹116.90
PIVOT
Resistance | |
---|---|
First Resistance | ₹118.800 |
Second Resistance | ₹122.600 |
Third Resistance | ₹124.500 |
Support | |
---|---|
First Resistance | ₹113.100 |
Second Resistance | ₹111.200 |
Third Resistance | ₹107.400 |
RSI | 17.935 |
MACD | -11.384 |
ADX | 10.471 |
CCI | -132.315 |
Delivery and Volume
About Parnax Lab Ltd
Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpar's prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company now has state-of-the-art accredited manufacturing facilities with high speed packing lines in Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh. Naxpar's key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHO-approved and EHS-compliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.
Managing Director
Baiju M Shah
Founded
1982
NSE Symbol
Parnax Lab Ltd Management
Name | Designation |
---|---|
Vindyak B Desai | Independent Director |
Prakash M Shah | Director & Chief Executive Off |
Baiju M Shah | Managing Director & CFO |
Ami M Shah | Non Executive Director |
T V Anantharaman | Independent Director |
Yogesh Varia | Independent Director |
Harish S Panpalia | Independent Director |